These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 326670)

  • 1. Protective role of complement in experimental Escherichia coli endocarditis.
    Durack DT; Beeson PB
    Infect Immun; 1977 Apr; 16(1):213-7. PubMed ID: 326670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Escherichia coli endocarditis in rats: roles of serum bactericidal activity and duration of catheter placement.
    Yersin B; Glauser MP; Guze PA; Guze LB; Freedman LR
    Infect Immun; 1988 May; 56(5):1273-80. PubMed ID: 3281906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement, serum bactericidal activity, and disseminated gram-negative infection.
    Leddy JP; Steigbigel RT
    Ann Intern Med; 1979 Jun; 90(6):984-5. PubMed ID: 109027
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis.
    Dankert J; van der Werff J; Zaat SA; Joldersma W; Klein D; Hess J
    Infect Immun; 1995 Feb; 63(2):663-71. PubMed ID: 7822036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunization and anticoagulation on the development of experimental Escherichia coli endocarditis.
    Thörig L; Thompson J; van Furth R
    Infect Immun; 1980 May; 28(2):325-30. PubMed ID: 6995305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in experimental streptococcal endocarditis: a monitor of therapeutic efficacy.
    Bayer AS; Theofilopoulos AN; Dixon FJ; Guze LB
    J Infect Dis; 1979 Jan; 139(1):1-8. PubMed ID: 438528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of granulocytes and monocytes in experimental Escherichia coli endocarditis.
    Meddens MJ; Thompson J; Bauer WC; van Furth R
    Infect Immun; 1984 Feb; 43(2):491-6. PubMed ID: 6363288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitral valve endocarditis caused by a serum-resistant strain of Escherichia coli.
    Watanakunakorn C; Kim J
    Clin Infect Dis; 1992 Feb; 14(2):501-5. PubMed ID: 1554838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nitrogen mustard on natural history of right-sided streptococcal endocarditis in rabbits: role for cellular host defenses.
    Yersin BR; Glauser MP; Freedman LR
    Infect Immun; 1982 Jan; 35(1):320-5. PubMed ID: 7054124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis.
    Contrepois A; Daldoss C; Pangon B; Garaud JJ; Kecir M; Sarrazin C; Vallois JM; Carbon C
    J Antimicrob Chemother; 1984 Jul; 14(1):51-7. PubMed ID: 6384175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental endocarditis in rabbits. 4. Experiments with Serratia marcescens: on the significance of serum susceptibility and proteolytic capacity of the strains and the influence of an indwelling catheter.
    Gutschik E; Norwood RS; Møller S; Olling S
    Acta Pathol Microbiol Scand B; 1980 Oct; 88(5):269-76. PubMed ID: 7008497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.
    Agüero ME; Cabello FC
    Infect Immun; 1983 Apr; 40(1):359-68. PubMed ID: 6339405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
    Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB
    Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of methicillin tolerance in experimental staphylococcal endocarditis.
    Goldman PL; Petersdorf RG
    Antimicrob Agents Chemother; 1979 Jun; 15(6):802-6. PubMed ID: 258111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation.
    Miller TE; Phillips S; Simpson IJ
    Clin Exp Immunol; 1978 Jul; 33(1):115-21. PubMed ID: 361314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis.
    Contrepois A; Vallois JM; Garaud JJ; Pangon B; Mohler J; Meulemans A; Carbon C
    J Antimicrob Chemother; 1986 Feb; 17(2):227-37. PubMed ID: 3516963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host factors in the resistance of newborn mice to K1 Escherichia coli infection.
    Pluschke G; Pelkonen S
    Microb Pathog; 1988 Feb; 4(2):93-102. PubMed ID: 3059139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
    Vaara M; Viljanen P; Vaara T; Mäkelä PH
    J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.
    Björkstén B; Bortolussi R; Gothefors L; Quie PG
    J Pediatr; 1976 Dec; 89(6):892-7. PubMed ID: 792409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.